Utilizing CRISPR for better antibiotics

Drug screening with Mobile-CRISPRi

15-Jan-2019 - A University of Wisconsin-Madison researcher and his collaborators at the University of California, San Francisco have repurposed the gene-editing tool CRISPR to study which genes are targeted by particular antibiotics, providing clues on how to improve existing antibiotics or develop new ...

Google provides open source library for quantum chemistry

Platform-independent solution to integrate future developments

26-Oct-2017 - Since physicists have been dealing with the theoretical description of molecules, the solving of quantum mechanical equations has been a major obstacle. This is supposed to be a thing of the past with the release of an open source based system. Google has introduced such a system to the public ...

Eurofins opens new faciltiy in Livingston

28-Sep-2017 - Eurofins Scientific (EUFI.PA), a world leader in bioanalytical testing, has today opened a new pharmaceutical chemistry, microbiology and water microbiology facility in Livingston, Scotland, following a £4 million investment. A plaque marking the opening of the laboratories at Brucefield Industry ...

Seeing more with PET scans

New chemistry for medical imaging

28-Jul-2017 - Researchers have found a surprisingly versatile workaround to create chemical compounds that could prove useful for medical imaging and drug development. The chemical mechanism, discovered by scientists at the Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) and UC ...

Eurofins to invest millions in new UK facility

20-Mar-2017 - Eurofins Scientific (EUFI.PA), a world leader in bioanalytical testing, has announced plans to establish a new pharmaceutical chemistry and microbiology facility in Livingston, Scotland as part of a £4 million investment. The announcement follows Eurofins’ acquisition of Exova’s pharmaceutical, ...

analytica Vietnam 2017: More exhibitors and a strong supporting program

23-Feb-2017 - analytica Vietnam is being held for the fifth time this year, and interest among companies is stronger than ever. Compared to the last time the fair was held (2015), approximately 15 percent more exhibitors are expected. Exhibition space is up by the same amount. Besides the product highlights of ...

Evotec Signs High Throughput Screening Agreement with Active Biotech

15-Mar-2010 - Evotec AG announced that it has entered into a collaboration with Active Biotech AB to identify small molecule modulators of a priority biological target, selected by Active Biotech, involved in immune disorders and cancer. Evotec will use its expertise and technologies in assay development, ...

Link Technologies secures exclusive license for ultra sensitive diagnostic probes

Deal marks the start of ongoing collaboration between Link and The University of Manchester

01-Dec-2009 - Link Technologies Ltd has announced an exclusive license deal with The University of Manchester Intellectual Property Limited (UMIP). Under the terms of the license for the University’s “exciplex” technology, Link will manufacture and sell highly sensitive exciplex-based diagnostic reagents ...

Evotec to Launch its First Innovation Centre for Fragment Based Drug Discovery

24-May-2007 - Evotec AG announced the launch of its Innovation Centre for Fragment Based Drug Discovery ('FBDD'). FBDD offers an alternative approach for identifying novel, small molecule hits (fragments) for a number of biological targets including those that have proved problematic using traditional drug ...

Galapagos expands and extends drug discovery collaboration with Amgen into 2008

04-Jan-2007 - Galapagos NV announced that its service division BioFocus DPI has expanded and extended its longstanding drug discovery collaboration with Amgen through 2007 and 2008. BioFocus DPI will continue to provide biology, computational and medicinal chemistry services and will supply ...